Asset Details
Do you wish to reserve the book?
The behavioral pharmacology of zolpidem: evidence for the functional significance of alpha 1-containing GABA sub(A) receptors
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The behavioral pharmacology of zolpidem: evidence for the functional significance of alpha 1-containing GABA sub(A) receptors
Do you wish to request the book?
The behavioral pharmacology of zolpidem: evidence for the functional significance of alpha 1-containing GABA sub(A) receptors
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The behavioral pharmacology of zolpidem: evidence for the functional significance of alpha 1-containing GABA sub(A) receptors
2014
Overview
Rationale: Zolpidem is a positive allosteric modulator of gamma -aminobutyric acid (GABA) with preferential binding affinity and efficacy for alpha 1-subunit containing GABA sub(A) receptors ( alpha 1-GABA sub(A)Rs). Over the last three decades, a variety of animal models and experimental procedures have been used in an attempt to relate the behavioral profile of zolpidem and classic benzodiazepines (BZs) to their interaction with alpha 1-GABA sub(A)Rs. Objectives: This paper reviews the results of rodent and non-human primate studies that have evaluated the effects of zolpidem on motor behaviors, anxiety, memory, food and fluid intake, and electroencephalogram (EEG) sleep patterns. Also included are studies that examined zolpidem's discriminative, reinforcing, and anticonvulsant effects as well as behavioral signs of tolerance and withdrawal. Results: The literature reviewed indicates that alpha 1-GABA sub(A)Rs play a principle role in mediating the hypothermic, ataxic-like, locomotor- and memory-impairing effects of zolpidem and BZs. Evidence also suggests that alpha 1-GABA sub(A)Rs play partial roles in the hypnotic, EEG sleep, anticonvulsant effects, and anxiolytic-like of zolpidem and diazepam. These studies also indicate that alpha 1-GABA sub(A)Rs play a more prominent role in mediating the discriminative stimulus, reinforcing, hyperphagic, and withdrawal effects of zolpidem and BZs in primates than in rodents. Conclusions: The psychopharmacological data from both rodents and non-human primates suggest that zolpidem has a unique pharmacological profile when compared with classic BZs. The literature reviewed here provides an important framework for studying the role of different GABA sub(A)R subtypes in the behavioral effects of BZ-type drugs and helps guide the development of new pharmaceutical agents for disorders currently treated with BZ-type drugs.
Subject
